IL177684A0 - Transdermal iontophoretic delivery of piperazinyl-2(3h)-benzoxazolone compounds - Google Patents

Transdermal iontophoretic delivery of piperazinyl-2(3h)-benzoxazolone compounds

Info

Publication number
IL177684A0
IL177684A0 IL177684A IL17768406A IL177684A0 IL 177684 A0 IL177684 A0 IL 177684A0 IL 177684 A IL177684 A IL 177684A IL 17768406 A IL17768406 A IL 17768406A IL 177684 A0 IL177684 A0 IL 177684A0
Authority
IL
Israel
Prior art keywords
piperazinyl
iontophoretic delivery
transdermal iontophoretic
benzoxazolone
compounds
Prior art date
Application number
IL177684A
Other versions
IL177684A (en
Original Assignee
Solvay Pharm Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP04101253A external-priority patent/EP1595542A1/en
Application filed by Solvay Pharm Bv filed Critical Solvay Pharm Bv
Publication of IL177684A0 publication Critical patent/IL177684A0/en
Publication of IL177684A publication Critical patent/IL177684A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A61N1/0432—Anode and cathode
    • A61N1/044—Shape of the electrode
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/325—Applying electric currents by contact electrodes alternating or intermittent currents for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A61N1/0432—Anode and cathode
    • A61N1/0436—Material of the electrode

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IL177684A 2004-03-26 2006-08-24 Use of piperazinyl-2(3h)-benzoxazolone compounds for the preparation of an iontophoretic device for the treatment of parkinson's disease and restless legs syndrome IL177684A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US55637504P 2004-03-26 2004-03-26
EP04101253A EP1595542A1 (en) 2004-03-26 2004-03-26 Transdermal iontophoretic delivery of piperazinyl-2(3H)-benzoxazolone compounds
PCT/EP2005/051401 WO2005107754A2 (en) 2004-03-26 2005-03-25 Transdermal iontophoretic delivery of piperazinyl-2(3h)-benzoxazolone compounds

Publications (2)

Publication Number Publication Date
IL177684A0 true IL177684A0 (en) 2006-12-31
IL177684A IL177684A (en) 2011-07-31

Family

ID=34968826

Family Applications (1)

Application Number Title Priority Date Filing Date
IL177684A IL177684A (en) 2004-03-26 2006-08-24 Use of piperazinyl-2(3h)-benzoxazolone compounds for the preparation of an iontophoretic device for the treatment of parkinson's disease and restless legs syndrome

Country Status (3)

Country Link
KR (1) KR20070012432A (en)
IL (1) IL177684A (en)
NO (1) NO20064865L (en)

Also Published As

Publication number Publication date
KR20070012432A (en) 2007-01-25
NO20064865L (en) 2006-12-20
IL177684A (en) 2011-07-31

Similar Documents

Publication Publication Date Title
HK1258903A1 (en) Anti-connexin compounds and therapeutic uses thereof
HK1120451A1 (en) Transdermal systems for the delivery of therapeutic agents including granisetron using iontophoresis
GB0423554D0 (en) Therapeutic compounds
HK1085394A1 (en) Uv stable transdermal therapeutic plaster
IL179145A0 (en) Therapeutic compounds
EP1973601A4 (en) Iontophoretic transdermal delivery of nicotine salts
EP1799271A4 (en) Delivery of polynucleotides
EP1796676A4 (en) Transdermal administration of phycotoxins
EP1824513A4 (en) Treatment of b-cell malignancies
GB0605715D0 (en) Treatment of laminitis
HK1098048A1 (en) Transdermal iontophoretic delivery of piperazinyl-2(3h)-benzoxazolone compounds
GB0420424D0 (en) Therapeutic compounds
IL177684A0 (en) Transdermal iontophoretic delivery of piperazinyl-2(3h)-benzoxazolone compounds
ZA200804266B (en) Therapeutic uses of steroidal compounds
EP1810673A4 (en) Therapeutic agent for interstitial cystitis
GB0425854D0 (en) Therapeutic treatment
IL180709A0 (en) Treatment of tumours
GB0423173D0 (en) Treatment of diabetes
GB0427138D0 (en) Therapeutic compounds
GB0417560D0 (en) Therapeutic compounds
GB0423767D0 (en) Therapeutic compounds
GB0722015D0 (en) Transdermal therapy
GB0408752D0 (en) Therapeutic treatment
IL182972A0 (en) Treatment of b-cell malignancies
GB0417695D0 (en) Electrochemical treatment of substrates

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees